{"id":64444,"date":"2023-06-09T15:30:59","date_gmt":"2023-06-09T19:30:59","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=64444"},"modified":"2023-06-26T15:04:55","modified_gmt":"2023-06-26T19:04:55","slug":"study-shows-metformin-lowers-long-covid-risk","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/study-shows-metformin-lowers-long-covid-risk\/","title":{"rendered":"Study Shows Metformin Lowers Long COVID Risk"},"content":{"rendered":"
John Buse, MD, PhD, co-authored a study showing that the common diabetes drug metformin substantially decreased the risk of developing long COVID after infection from SARS-CoV-2. The clinical trial was led by researchers at the University of Minnesota.<\/em><\/p>\n In a new study<\/a> published in The Lancet Infectious Diseases<\/em>, University of Minnesota researchers and colleagues found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.<\/p>\n The study, called COVID-OUT, investigated if early outpatient COVID-19 treatment with metformin, ivermectin or fluvoxamine could prevent long COVID. Long COVID is a chronic illness that can affect up to 10% of people who have had COVID-19.<\/p>\n \u201cNot only did we demonstrate that metformin, an inexpensive and safe treatment, may prevent the development of long COVID in many people, but we validated that long COVID is a real disease in that a 14-day treatment can reduce the risk of long COVID symptoms and a doctor\u2019s diagnosis over many months,\u201d said John Buse, MD, PhD, the Verne S. Caviness Distinguished Professor of Medicine and senior associate dean for clinical research at the ºÚÁÏÍø.<\/p>\n Read more<\/a> about the study at the ºÚÁÏÍø SOM newsroom.<\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" John Buse, MD, PhD, co-authored a study showing that the common diabetes drug metformin substantially decreased the risk of developing long COVID after infection from SARS-CoV-2. The clinical trial was led by researchers at the University of Minnesota. In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers and colleagues found … Read more<\/a><\/p>\n","protected":false},"author":112673,"featured_media":20255,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[96,2],"tags":[632],"class_list":["post-64444","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-endocrinology-metabolism","category-news","tag-632","odd"],"acf":[],"yoast_head":"\n
\n